1-3 of 3
Ana E Rodríguez
Close
Sort by
Journal Articles

A Targeted Resequencing Study Allows the Detection of a Common Polymorphism At Mirna-223 Binding Site in 3′Untranslated Region Which Deregulates HSP90B1 Expression in Chronic Lymphocytic Leukemia

Ana E Rodríguez, Dalia Qwaider, Rocío Benito, PhD, Irena Misiewicz-Krzeminska, María Hernández-Sánchez, M Eugenia Sarasquete, Jesús F San Miguel, MD, Jose Ángel Hernández-Rivas, Norma Gutierrez, Jesús M Hernández-Rivas
Journal: Blood
Blood (2012) 120 (21): 1776.
https://doi.org/10.1182/blood.V120.21.1776.1776
Published: 2012
Journal Articles

Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14.

Ana E Rodríguez, Jose Ángel Hernández-Rivas, Alberto Risueño, Encarna Fermiñán, Natalia de las Heras, Alfonso Garcia de Coca, Carlos Aguilar, Juan Nicolás Rodríguez, Josefina Galende, Javier de las Rivas, Jesús F San Miguel, MD, Marcos González, Jesús M Hernández-Rivas
Journal: Blood
Blood (2012) 120 (21): 2871.
https://doi.org/10.1182/blood.V120.21.2871.2871
Published: 2012
Journal Articles

The Correlation Between Deletion Architecture, ATM Mutational Status and BIRC3 Disruption in 11q-Deleted CLL

Matthew JJ Rose-Zerilli, PhD, Jade Forster, Helen Parker, PhD, Anton Parker, Ana E Rodríguez, Tracy Chaplin, Anne Gardiner, Andrew Collins, PhD, Bryan D Young, PhD, Tatjana Stankovic, MD., PhD, David Oscier, MD, Jonathan C. Strefford, BSc, PhD
Journal: Blood
Blood (2012) 120 (21): 658.
https://doi.org/10.1182/blood.V120.21.658.658
Published: 2012